Detailed answers about PHARMAPRECISION & INNOVATION LTD, including incorporation, status, business activity, and accounts information.
When was PHARMAPRECISION & INNOVATION LTD founded?
PHARMAPRECISION & INNOVATION LTD was officially incorporated on 13 January 2026 and is registered under company number 16960750. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PHARMAPRECISION & INNOVATION LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PHARMAPRECISION & INNOVATION LTD?
PHARMAPRECISION & INNOVATION LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PHARMAPRECISION & INNOVATION LTD do?
PHARMAPRECISION & INNOVATION LTD operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 62090 - Other information technology service activities, 74909 - Other professional, scientific and technical activities n.e.c., 85590 - Other education n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is PHARMAPRECISION & INNOVATION LTD's registered address?
The registered office address of PHARMAPRECISION & INNOVATION LTD is 11 BLACKSMITHS MEADOW, OXFORD, ENGLAND, OX4 7YF. This is the official address filed with Companies House for legal and statutory correspondence.
Is PHARMAPRECISION & INNOVATION LTD financially stable?
Financial accounts for PHARMAPRECISION & INNOVATION LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.